PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock IBD Center, Lebanon, NH, USA.\', \'Gastroenterology Department, Royal Melbourne Hospital, Melbourne, VIC, Australia.\', \'Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Division of Pediatric Gastroenterology, Goryeb Children\'s Hospital, Morristown, NJ, USA.\', \'Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Departments of Infectious Diseases and Internal Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.\', \'Department of Infectious Diseases, St Vincent\'s Hospital, Sydney, NSW, Australia.\', \'Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Department of Gastroenterology, Evaggelismos-Ophthalmiatreion Athinon-Polykliniki GHA, Athens, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ecco-jcc/jjaa135
?:doi
?:hasPublicationType
?:journal
  • Journal of Crohn\'s & colitis
is ?:pmid of
?:pmid
?:pmid
  • 33085972
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all